SPP1 and cancer: It is clear from our study that SPP1 (secreted phosphoprotein 1), also called as osteopontin, is highly upregulated in all the tested cancer samples and also has been reported in other population studies; hence, SPP1 emerges as a potential prognostic biomarker for cervical cancer screening in women [28, 29].